ID

32718

Beschrijving

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator; ODM derived from: https://clinicaltrials.gov/show/NCT00631007

Link

https://clinicaltrials.gov/show/NCT00631007

Trefwoorden

Versies (1)
  1. 13-11-18 13-11-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

13 november 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes Mellitus NCT00631007

Engels

Eligibility Type 2 Diabetes Mellitus NCT00631007

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of type 2 diabetes and on either sulfonylurea monotherapy or sulfonylurea plus metformin combination therapy for at least 3 months at stable dose
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent | Sulfonylureas Dose Stable | Metformin Dose Stable | Combined Modality Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0038766
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4]
C0009429
males and females (of non-childbearing potential or who are using dual barrier methods of contraception) between 30 and 75 years of age
Beschrijving

Age | Female infertility | Gender Barrier Contraception Double

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021361
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0004764
UMLS CUI [3,3]
C0205173
hba1c must be ≥7.5% and ≤10% at screening
Beschrijving

Hemoglobin A1c measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0474680
fasting plasma glucose must be <240 mg/dl at screening
Beschrijving

Plasma fasting glucose measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0583513
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of type 1 diabetes
Beschrijving

Diabetes Mellitus, Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011854
history of diabetic ketoacidosis
Beschrijving

Diabetic Ketoacidosis

Datatype

boolean

Alias
UMLS CUI [1]
C0011880
nyha class iii or iv cardiac status or hospitalization for congestive heart failure within 6 weeks prior to visit 1
Beschrijving

Cardiac Status New York Heart Association Classification | Hospitalization Due to Congestive heart failure

Datatype

boolean

Alias
UMLS CUI [1,1]
C1999091
UMLS CUI [1,2]
C1275491
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0018802
treatment with any non-peroxisome proliferator-activated receptor (non-ppar) antidiabetic agent, investigational or approved, other than metformin or permitted sulfonylureas within 3 months prior to screening
Beschrijving

Antidiabetics Investigational | Antidiabetics Approved | Exception Peroxisome Proliferator-Activated Receptors | Exception Metformin | Exception Sulfonylureas

Datatype

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1517586
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C0205540
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0166418
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0025598
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0038766
treatment with rosiglitazone, pioglitazone, or any ppar investigational antidiabetic agent within 6 month prior to screening
Beschrijving

rosiglitazone | pioglitazone | Antidiabetics Investigational PPAR

Datatype

boolean

Alias
UMLS CUI [1]
C0289313
UMLS CUI [2]
C0071097
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1517586
UMLS CUI [3,3]
C0166418
body mass index >45 kg/m2
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
fasting triglycerides >500 mg/dl
Beschrijving

Serum fasting triglyceride measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0582824
uncontrolled hypertension (sitting systolic blood pressure >160 mmhg and/or sitting diastolic blood pressure >100 mmhg
Beschrijving

Uncontrolled hypertension | Sitting systolic blood pressure | Sitting diastolic blood pressure

Datatype

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C1319893
UMLS CUI [3]
C1319894
presence of diabetic complications, which in the opinion of the investigator, would complicate the subject's participation in the study (i.e., require initiation of new medication)
Beschrijving

Complications of Diabetes Mellitus Complicating Study Subject Participation Status | Patient need for Medication New

Datatype

boolean

Alias
UMLS CUI [1,1]
C0342257
UMLS CUI [1,2]
C1522701
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0205314
Terug naar het begin van de pagina

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00631007

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Sulfonylureas Dose Stable | Metformin Dose Stable | Combined Modality Therapy
Item
diagnosis of type 2 diabetes and on either sulfonylurea monotherapy or sulfonylurea plus metformin combination therapy for at least 3 months at stable dose
boolean
C0011860 (UMLS CUI [1])
C0038766 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0025598 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0009429 (UMLS CUI [4])
Age | Female infertility | Gender Barrier Contraception Double
Item
males and females (of non-childbearing potential or who are using dual barrier methods of contraception) between 30 and 75 years of age
boolean
C0001779 (UMLS CUI [1])
C0021361 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0004764 (UMLS CUI [3,2])
C0205173 (UMLS CUI [3,3])
Hemoglobin A1c measurement
Item
hba1c must be ≥7.5% and ≤10% at screening
boolean
C0474680 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fasting plasma glucose must be <240 mg/dl at screening
boolean
C0583513 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetic Ketoacidosis
Item
history of diabetic ketoacidosis
boolean
C0011880 (UMLS CUI [1])
Cardiac Status New York Heart Association Classification | Hospitalization Due to Congestive heart failure
Item
nyha class iii or iv cardiac status or hospitalization for congestive heart failure within 6 weeks prior to visit 1
boolean
C1999091 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0019993 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0018802 (UMLS CUI [2,3])
Antidiabetics Investigational | Antidiabetics Approved | Exception Peroxisome Proliferator-Activated Receptors | Exception Metformin | Exception Sulfonylureas
Item
treatment with any non-peroxisome proliferator-activated receptor (non-ppar) antidiabetic agent, investigational or approved, other than metformin or permitted sulfonylureas within 3 months prior to screening
boolean
C0935929 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C0205540 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0166418 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0025598 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0038766 (UMLS CUI [5,2])
rosiglitazone | pioglitazone | Antidiabetics Investigational PPAR
Item
treatment with rosiglitazone, pioglitazone, or any ppar investigational antidiabetic agent within 6 month prior to screening
boolean
C0289313 (UMLS CUI [1])
C0071097 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1517586 (UMLS CUI [3,2])
C0166418 (UMLS CUI [3,3])
Body mass index
Item
body mass index >45 kg/m2
boolean
C1305855 (UMLS CUI [1])
Serum fasting triglyceride measurement
Item
fasting triglycerides >500 mg/dl
boolean
C0582824 (UMLS CUI [1])
Uncontrolled hypertension | Sitting systolic blood pressure | Sitting diastolic blood pressure
Item
uncontrolled hypertension (sitting systolic blood pressure >160 mmhg and/or sitting diastolic blood pressure >100 mmhg
boolean
C1868885 (UMLS CUI [1])
C1319893 (UMLS CUI [2])
C1319894 (UMLS CUI [3])
Complications of Diabetes Mellitus Complicating Study Subject Participation Status | Patient need for Medication New
Item
presence of diabetic complications, which in the opinion of the investigator, would complicate the subject's participation in the study (i.e., require initiation of new medication)
boolean
C0342257 (UMLS CUI [1,1])
C1522701 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0686904 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0205314 (UMLS CUI [2,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial